Gentuzumabe

Gentuzumab is the active substance of an antineoplastic medicine known commercially as Mylotarg.

This injectable drug is indicated for the treatment of cancer, since it acts by destroying the cancerous cells and preventing them from spreading to other organs of the body.

Indications of Gentuzumabe

Acute myeloid leukemia.

Side Effects of Gentuzumab

Fever; Headache; dizziness; insomnia; tremors; weakness; back pain; nausea; vomiting; diarrhea; constipation; abdominal pain; burning; difficulty breathing; bleeding in the nose; cough; pharyngitis; rhinitis; sinusitis; pneumonia; decreased potassium in the blood; increased cholesterol; decreased magnesium in the blood; reactions at the injection site; pain; skin rash; blood spots on the skin; bleeding; high or low pressure; increased heart rate; vaginal bleeding; blood in the urine; herpes simplex.

Contraindications of Gentuzumab

Pregnancy risk D; women in the lactation phase; children; Hipersensibility to any of the formula's components.

How to use Gentuzumabe

Injectable use

Adults

• Apply 9 mg Gentuzumab per square meter of body surface. The dose should be repeated after 14 days.